Level Chart

Basic Info

Abbott Laboratories (ABT) - Established Pharmaceutical Products Revenue is at a current level of 5.066B, up from 4.912B one year ago. This is a change of 3.14% from one year ago.

Abbott Laboratories Established Pharmaceutical Products Revenue refers to the income generated by the company's portfolio of pharmaceutical products that have already been established in the market.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 5.066B
Latest Period 2023
Last Updated Jan 31 2024, 08:49 EST
Next Release Jan 31 2025, 08:30 EST (E)
Average Growth Rate 5.80%
Value from 1 Year Ago 4.912B
Change from 1 Year Ago 3.14%
Frequency Yearly
Unit USD
Adjustment N/A

Historical Data

View and export this data back to 2012. Upgrade now.
Date Value
December 31, 2023 5.066B
December 31, 2022 4.912B
December 31, 2021 4.718B
December 31, 2020 4.303B
December 31, 2019 4.486B
December 31, 2018 4.422B
Date Value
December 31, 2017 4.287B
December 31, 2016 3.859B
December 31, 2015 3.72B
December 31, 2014 3.118B
December 31, 2013 2.862B
December 31, 2012 2.769B

Basic Info

Abbott Laboratories (ABT) - Established Pharmaceutical Products Revenue is at a current level of 5.066B, up from 4.912B one year ago. This is a change of 3.14% from one year ago.

Abbott Laboratories Established Pharmaceutical Products Revenue refers to the income generated by the company's portfolio of pharmaceutical products that have already been established in the market.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 5.066B
Latest Period 2023
Last Updated Jan 31 2024, 08:49 EST
Next Release Jan 31 2025, 08:30 EST (E)
Average Growth Rate 5.80%
Value from 1 Year Ago 4.912B
Change from 1 Year Ago 3.14%
Frequency Yearly
Unit USD
Adjustment N/A

Related Securities

Symbol Name Change %
ABT Abbott Laboratories -0.33%